Received Feb 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5GY34 | IM / RA |
Patient received 2 doses of Boostrix in a time frame of less than one year. First dose was 9/3/25 and second dose was 2/24/26. Patient should not have received a second dose of Boostrix. Patient is okay and experienced no side effects from the second vaccine.
Unknown
Diabetes and Dyslipidemia
Metformin, Jardiance, Glipizide, Metoprolol, Ezetimibe, Atorvastatin, Ozempic
NKDA